###begin article-title 0
###xml 114 120 114 115 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fn1" ref-type="fn">&#8224;</xref>
Contribution of Amino Acid Region 334-335 from Factor Va Heavy Chain to the Catalytic Efficiency of Prothrombinasedagger
###end article-title 0
###begin p 1
This work was supported by Grant R01 HL-73343 from the National Heart, Lung and Blood Institute (to M.K.), by National Science Foundation Computational Grant MCB060021T under the NSF programs Partnerships for Advanced Computational Infrastructure Distributed Terascale Facility and Terascale Extensions: Enhancement to the Extensible Terascale Facility (to M.K.), by a predoctoral fellowship from Cellular and Molecular Medicine Specialization at Cleveland State University (to T.O.), and Predoctoral Fellowship 0715435B from the American Heart Association Ohio Valley Affiliate (to M. A. Bukys).
###end p 1
###begin p 2
Cleveland State University.
###end p 2
###begin p 3
Present address: Department of Plastic Surgery, University of Texas, Southwestern, 1801 Inwood Rd., Dallas, TX 75390.
###end p 3
###begin p 4
Present address: The Hamner Institutes for Health Sciences, Six Davis Drive, Research Triangle Park, NC 27709.
###end p 4
###begin p 5
Cleveland Clinic.
###end p 5
###begin p 6
###xml 180 199 180 199 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>
This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
###end p 6
###begin p 7
40.75
###end p 7
###begin p 8
###xml 0 0 0 0 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="bi-2008-00057r_0005" id="tgr1"/>

###end p 8
###begin p 9
###xml 39 42 39 42 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 45 48 45 48 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 51 54 51 54 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 61 64 61 64 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 368 371 368 371 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 377 380 377 380 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 485 488 485 488 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 500 503 498 501 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 519 521 515 517 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 528 531 524 527 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 543 546 537 540 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 562 564 554 556 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 610 612 602 604 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 626 628 618 620 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 635 636 627 628 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 636 637 628 629 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 667 668 659 660 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 668 669 660 661 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 713 715 705 707 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 788 789 780 781 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 789 792 781 784 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 835 837 827 829 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 851 853 843 845 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 940 942 932 934 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 955 957 947 949 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 1126 1128 1106 1108 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1322 1325 1302 1305 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 1326 1329 1306 1309 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 1335 1338 1315 1318 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 1339 1342 1319 1322 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1535 1537 1515 1517 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
We have demonstrated that amino acids E323, Y324, E330, and V331 from the factor Va heavy chain are required for the interaction of the cofactor with factor Xa and optimum rates of prothrombin cleavage. We have also shown that amino acid region 332-336 contains residues that are important for cofactor function. Using overlapping peptides, we identified amino acids D334 and Y335 as contributors to cofactor activity. We constructed recombinant factor V molecules with the mutations D334 --> K and Y335 --> F (factor VKF) and D334 --> A and Y335 --> A (factor VAA). Kinetic studies showed that while factor VaKF and factor VaAA had a KD for factor Xa similar to the KD observed for wild-type factor Va (factor VaWT), the clotting activities of the mutant molecules were impaired and the kcat of prothrombinase assembled with factor VaKF and factor VaAA was reduced. The second-order rate constant of prothrombinase assembled with factor VaKF or factor VaAA for prothrombin activation was approximately10-fold lower than the second-order rate constant for the same reaction catalyzed by prothrombinase assembled with factor VaWT. We also created quadruple mutants combining mutations in the amino acid region 334-335 with mutations at the previously identified amino acids that are important for factor Xa binding (i.e., E323Y324 and E330V331). Prothrombinase assembled with the quadruple mutant molecules displayed a second-order rate constant up to 400-fold lower than the values obtained with prothrombinase assembled with factor VaWT. The data demonstrate that amino acid region 334-335 is required for the rearrangement of enzyme and substrate necessary for efficient catalysis of prothrombin by prothrombinase.
###end p 9
###begin title 10

###end title 10
###begin p 11
###xml 327 328 327 328 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref1">1</xref>
###xml 329 330 329 330 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref3">3</xref>
###xml 503 506 503 506 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 514 517 514 517 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">320</sup>
###xml 581 582 581 582 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref4">4</xref>
###xml 583 585 583 585 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref14">14</xref>
###xml 850 851 850 851 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref7">7</xref>
###xml 852 853 852 853 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref8">8</xref>
###xml 854 856 854 856 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref15">15</xref>
###xml 905 908 905 908 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">320</sup>
###xml 973 976 973 976 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 1014 1015 1014 1015 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref4">4</xref>
###xml 1016 1018 1016 1018 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref14">14</xref>
The mainstay of the hemostasis process is the generation of thrombin, which in turn promotes the assembly of the fibrin plug following vascular injury. The prothrombinase complex is composed of the enzyme, factor Xa, and the protein cofactor, factor Va, associated in the presence of divalent metal ions on a membrane surface (1-3). This complex catalyzes the activation of prothrombin to its active form, thrombin. Factor Xa alone can activate prothrombin by two sequential proteolytic cleavages at Arg271 and Arg320 resulting in the intermediates fragment 1.2 and prethrombin 2 (4-14). The overall rate of this reaction is not compatible with survival; however, incorporation of the cofactor, factor Va, into prothrombinase reverses the order of the proteolytic cleavages and increases the catalytic activity of factor Xa by 5 orders of magnitude (7,8,15). The first, factor Va-dependent cleavage at Arg320 produces the intermediate meizothrombin. Further cleavage at Arg271 generates thrombin and fragment 1.2 (4-14). The regulation of this key step in the blood coagulation cascade has been under intense investigation for many years.
###end p 11
###begin p 12
###xml 67 68 67 68 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 68 69 68 69 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 137 139 137 139 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref16">16</xref>
###xml 253 256 253 256 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">709</sup>
###xml 261 265 261 265 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1018</sup>
###xml 274 278 274 278 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1545</sup>
###xml 344 345 344 345 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 345 346 345 346 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 418 419 418 419 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 419 420 419 420 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 431 433 431 433 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref17">17</xref>
###xml 443 444 443 444 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">1</xref>
###xml 589 590 589 590 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 613 615 613 615 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref18">18</xref>
###xml 731 733 731 733 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref19">19</xref>
###xml 476 482 <span type="species:ncbi:9913">bovine</span>
###xml 703 708 <span type="species:ncbi:9606">human</span>
Plasma factor V circulates as an inactive protein cofactor with an Mr of 330000 that does not participate in the prothrombinase complex (16). Factor V must first be activated to factor Va by thrombin through three sequential proteolytic cleavages at Arg709, Arg1018, and Arg1545 to produce a heavy chain, composed of amino acid residues 1-709 (Mr = 105000) and a light chain composed of amino acid residues 1546-2196 (Mr = 74000) (17) (Figure 1). The crystal structure of the bovine factor Va molecule lacking the entire A2 domain and the acidic COOH terminus of the heavy chain (factor Vai) has been determined (18). Using this crystal structure as a template, we have provided a complete model of the human cofactor in solution (19). This model allows for the identification of the structural perturbations of point mutations on the overall tertiary cofactor structure.
###end p 12
###begin p 13
###xml 252 255 252 255 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">709</sup>
###xml 260 264 260 264 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1018</sup>
###xml 273 277 273 277 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1545</sup>
###xml 886 889 886 889 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">709</sup>
###xml 26 31 <span type="species:ncbi:9606">human</span>
Proteolytic processing of human factor V. Factor V is composed of 2196 amino acids and has three A domains (A1, A2, and A3), a connecting B region, and two C domains (C1 and C2). The procofactor is activated following three cleavages by thrombin at Arg709, Arg1018, and Arg1545. The latter cleavage is the last to occur and is a prerequisite for light chain formation and maximum cofactor activity generation. These cleavages release the active cofactor composed of heavy and light chains associated in the presence of divalent metal ions, and two activation fragments. The mutations within a 45-amino acid region of the A2 domain of the heavy chain of the molecule that is involved in cofactor activity (hatched box) are indicated together with the designation for the recombinant mutant factor V molecules created and used throughout the paper. The black box preceding cleavage at Arg709 depicts the acidic COOH-terminal region of factor Va that is essential for optimum cofactor activity.
###end p 13
###begin p 14
###xml 108 110 108 110 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref20">20</xref>
###xml 111 113 111 113 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 271 273 271 273 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref22">22</xref>
###xml 274 276 274 276 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
###xml 586 588 586 588 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 705 707 705 707 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref25">25</xref>
###xml 718 720 718 720 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref26">26</xref>
###xml 730 732 730 732 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref27">27</xref>
###xml 748 750 748 750 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref28">28</xref>
###xml 1042 1044 1042 1044 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 1045 1047 1045 1047 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 1123 1126 1123 1126 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 1131 1134 1131 1134 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">336</sup>
###xml 1251 1253 1251 1253 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 698 703 <span type="species:ncbi:9606">human</span>
###xml 710 716 <span type="species:ncbi:9913">bovine</span>
###xml 723 728 <span type="species:ncbi:10090">mouse</span>
Both chains of factor Va have been shown to be required for the interaction of the cofactor with factor Xa (20,21). While the binding sites on the light chain remain to be identified, several binding sites for factor Xa on the factor Va heavy chain have been delineated (22-24). Analysis of the inactivation fragments of factor Va by plasmin and activated protein C (APC) demonstrated that amino acid region 307-348 is critical for factor Va cofactor function. A synthetic peptide spanning this amino acid region was found to be a good inhibitor of factor V/Va clotting activity [N42R (23)]. This region of factor Va is thought to be important for cofactor function since it is 82% conserved among human (25), bovine (26), mouse (27), and porcine (28) species. Using overlapping synthetic peptides from this region and recombinant factor Va molecules, we have demonstrated that amino acid region 323-331 of the factor Va heavy chain contains critical amino acid residues responsible for the direct interaction of the cofactor with factor Xa (23,29). In addition, our initial data also demonstrated that amino acid sequence 332IWDYA336, which is continuous to the factor Xa binding site, was also involved in the inhibition of prothrombinase activity (23). This study was undertaken to improve our understanding of the precise contribution of amino acid region 332-336 of the factor Va heavy chain to the catalytic efficiency of prothrombinase.
###end p 14
###begin title 15
Experimental Procedures
###end title 15
###begin title 16
Materials, Reagents, and Proteins
###end title 16
###begin p 17
###xml 35 36 35 36 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 77 78 77 78 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 106 107 106 107 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 367 368 367 368 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 398 399 394 395 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fn2" ref-type="fn">1</xref>
###xml 404 405 400 401 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 512 513 504 505 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 982 983 974 975 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1493 1495 1481 1483 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">HC</sub>
###xml 1510 1512 1494 1496 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">LC</sub>
###xml 1666 1667 1646 1647 <label xmlns:mml="http://www.w3.org/1998/Math/MathML">1</label>
###xml 1686 1687 1666 1667 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1718 1719 1694 1695 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1981 1984 1953 1956 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 2064 2066 2036 2038 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 2116 2118 2088 2090 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 2168 2171 2140 2143 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2183 2186 2153 2156 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2203 2205 2171 2173 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 2255 2258 2223 2226 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2270 2273 2236 2239 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2290 2292 2254 2256 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF</sup>
###xml 2342 2345 2306 2309 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 2357 2360 2319 2322 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 2377 2379 2337 2339 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI</sup>
###xml 2429 2432 2389 2392 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 2444 2447 2402 2405 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 2463 2468 2419 2424 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">I332A</sup>
###xml 2517 2520 2473 2476 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 2536 2541 2490 2495 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">W333A</sup>
###xml 2590 2593 2544 2547 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 2610 2615 2562 2567 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 2685 2688 2637 2640 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 2697 2700 2647 2650 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 2709 2712 2657 2660 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2725 2728 2671 2674 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2745 2750 2689 2694 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 2820 2823 2764 2767 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 2832 2835 2774 2777 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 2844 2847 2784 2787 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2860 2863 2798 2801 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2880 2885 2816 2821 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 2955 2958 2891 2894 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 2967 2970 2901 2904 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 2979 2982 2911 2914 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2995 2998 2925 2928 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 3015 3020 2943 2948 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 3090 3093 3018 3021 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 3102 3105 3028 3031 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 3114 3117 3038 3041 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 3130 3133 3052 3055 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 1667 3140 1647 3060 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="18">Abbreviations: PS, <sc>l</sc>-&#945;-phosphatidylserine; PC, <sc>l</sc>-&#945;-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); HPLC, high-performance liquid chromatography; SDS-PAGE, sodium dodecyl sulfate&#8722;polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; [OG<sub>488</sub>]-EGR-hXa, factor Xa labeled in the active site with Oregon Green 488; factor Va<sup>WT</sup>, recombinant wild-type human factor Va; factor Va<sup>KF</sup>, recombinant human factor Va with the mutations D<sup>334</sup> &#8594; K and Y<sup>335</sup> &#8594; F; factor Va<sup>AA</sup>, recombinant human factor Va with the mutations D<sup>334</sup> &#8594; A and Y<sup>335</sup> &#8594; A; factor Va<sup>FF</sup>, recombinant human factor Va with the mutations E<sup>323</sup> &#8594; F and Y<sup>324</sup> &#8594; F; factor Va<sup>MI</sup>, recombinant human factor Va with the mutations E<sup>330</sup> &#8594; M and V<sup>331</sup> &#8594; I; factor V<sup>I332A</sup>, recombinant human factor Va with the mutation I<sup>332</sup> &#8594; A; factor V<sup>W333A</sup>, recombinant human factor Va with the mutation W<sup>333</sup> &#8594; A; factor Va<sup>FF/KF</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>323</sup> &#8594; F, Y<sup>324</sup> &#8594; F, D<sup>334</sup> &#8594; K, and Y<sup>335</sup> &#8594; F; factor Va<sup>MI/KF</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>330</sup> &#8594; M, V<sup>331</sup> &#8594; I, D<sup>334</sup> &#8594; K, and Y<sup>335</sup> &#8594; F; factor Va<sup>FF/AA</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>323</sup> &#8594; F, Y<sup>324</sup> &#8594; F, D<sup>334</sup> &#8594; A, and Y<sup>335</sup> &#8594; A; factor Va<sup>MI/AA</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>330</sup> &#8594; M, V<sup>331</sup> &#8594; I, D<sup>334</sup> &#8594; A, and Y<sup>335</sup> &#8594; A.</p>
###xml 1666 3140 1646 3060 <fn xmlns:mml="http://www.w3.org/1998/Math/MathML" id="fn2"><label>1</label><p textid="18">Abbreviations: PS, <sc>l</sc>-&#945;-phosphatidylserine; PC, <sc>l</sc>-&#945;-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); HPLC, high-performance liquid chromatography; SDS-PAGE, sodium dodecyl sulfate&#8722;polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; [OG<sub>488</sub>]-EGR-hXa, factor Xa labeled in the active site with Oregon Green 488; factor Va<sup>WT</sup>, recombinant wild-type human factor Va; factor Va<sup>KF</sup>, recombinant human factor Va with the mutations D<sup>334</sup> &#8594; K and Y<sup>335</sup> &#8594; F; factor Va<sup>AA</sup>, recombinant human factor Va with the mutations D<sup>334</sup> &#8594; A and Y<sup>335</sup> &#8594; A; factor Va<sup>FF</sup>, recombinant human factor Va with the mutations E<sup>323</sup> &#8594; F and Y<sup>324</sup> &#8594; F; factor Va<sup>MI</sup>, recombinant human factor Va with the mutations E<sup>330</sup> &#8594; M and V<sup>331</sup> &#8594; I; factor V<sup>I332A</sup>, recombinant human factor Va with the mutation I<sup>332</sup> &#8594; A; factor V<sup>W333A</sup>, recombinant human factor Va with the mutation W<sup>333</sup> &#8594; A; factor Va<sup>FF/KF</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>323</sup> &#8594; F, Y<sup>324</sup> &#8594; F, D<sup>334</sup> &#8594; K, and Y<sup>335</sup> &#8594; F; factor Va<sup>MI/KF</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>330</sup> &#8594; M, V<sup>331</sup> &#8594; I, D<sup>334</sup> &#8594; K, and Y<sup>335</sup> &#8594; F; factor Va<sup>FF/AA</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>323</sup> &#8594; F, Y<sup>324</sup> &#8594; F, D<sup>334</sup> &#8594; A, and Y<sup>335</sup> &#8594; A; factor Va<sup>MI/AA</sup>, quadruple mutant of recombinant human factor Va with the mutations E<sup>330</sup> &#8594; M, V<sup>331</sup> &#8594; I, D<sup>334</sup> &#8594; A, and Y<sup>335</sup> &#8594; A.</p></fn>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 258 263 <span type="species:ncbi:9940">sheep</span>
###xml 815 820 <span type="species:ncbi:9606">Human</span>
###xml 1048 1053 <span type="species:ncbi:9606">human</span>
###xml 1068 1073 <span type="species:ncbi:9606">human</span>
###xml 2090 2095 <span type="species:ncbi:9606">human</span>
###xml 2132 2137 <span type="species:ncbi:9606">human</span>
###xml 2219 2224 <span type="species:ncbi:9606">human</span>
###xml 2306 2311 <span type="species:ncbi:9606">human</span>
###xml 2393 2398 <span type="species:ncbi:9606">human</span>
###xml 2482 2487 <span type="species:ncbi:9606">human</span>
###xml 2555 2560 <span type="species:ncbi:9606">human</span>
###xml 2649 2654 <span type="species:ncbi:9606">human</span>
###xml 2784 2789 <span type="species:ncbi:9606">human</span>
###xml 2919 2924 <span type="species:ncbi:9606">human</span>
###xml 3054 3059 <span type="species:ncbi:9606">human</span>
Diisopropyl fluorophosphate (DFP), O-phenylenediamine (OPD) dihydrochloride, N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid (Hepes), Trizma (Tris base), and Coomassie Blue R-250 were purchased from Sigma (St. Louis, MO). Secondary anti-mouse and anti-sheep IgG coupled to peroxidase were purchased from Southern Biotechnology Associates Inc. (Birmingham, AL). l-alpha-Phosphatidylserine (PS)1 and l-alpha-phosphatidylcholine (PC) were from Avanti Polar Lipids (Alabaster, AL). Chemiluminescent reagent ECL+ and heparin-Sepharose were from AmershamPharmacia Biotech Inc. (Piscataway, NJ). Normal reference plasma and the chromogenic substrates Spectrozyme-TH and Spectrozyme-Xa were from American Diagnostica Inc. (Greenwich, CT). RecombiPlasTin was purchased from Instrumentation Laboratory (Lexington, MA). Human factor Xa was from Enzyme Research Laboratories (South Bend, IN). Factor V-deficient plasma was from Research Proteins Inc. (Essex Junction, VT). Dansylarginine-N-(3-ethyl-1,5-pentanediyl) amide (DAPA), RVV-factor V activator, human thrombin, and human prothrombin were purchased from Haematologic Technologies Inc. (Essex Junction, VT). Factor V cDNA (ATCC catalog no. 40515 pMT2-V) was from American Type Culture Collection (Manassas, VA). All restriction enzymes were from New England Biolabs (Beverly, MA). All molecular biology and tissue culture reagents and media were from Gibco, Invitrogen Corp. (Grand Island, NY), or as indicated. Monoclonal antibodies alphaHFVHC17 and alphaHFVLC9 and monoclonal antibody alphaHFV1 coupled to Sepharose were provided by K. G. Mann (Department of Biochemistry, University of Vermont, Burlington, VT). 1Abbreviations: PS, l-alpha-phosphatidylserine; PC, l-alpha-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); HPLC, high-performance liquid chromatography; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; [OG488]-EGR-hXa, factor Xa labeled in the active site with Oregon Green 488; factor VaWT, recombinant wild-type human factor Va; factor VaKF, recombinant human factor Va with the mutations D334 --> K and Y335 --> F; factor VaAA, recombinant human factor Va with the mutations D334 --> A and Y335 --> A; factor VaFF, recombinant human factor Va with the mutations E323 --> F and Y324 --> F; factor VaMI, recombinant human factor Va with the mutations E330 --> M and V331 --> I; factor VI332A, recombinant human factor Va with the mutation I332 --> A; factor VW333A, recombinant human factor Va with the mutation W333 --> A; factor VaFF/KF, quadruple mutant of recombinant human factor Va with the mutations E323 --> F, Y324 --> F, D334 --> K, and Y335 --> F; factor VaMI/KF, quadruple mutant of recombinant human factor Va with the mutations E330 --> M, V331 --> I, D334 --> K, and Y335 --> F; factor VaFF/AA, quadruple mutant of recombinant human factor Va with the mutations E323 --> F, Y324 --> F, D334 --> A, and Y335 --> A; factor VaMI/AA, quadruple mutant of recombinant human factor Va with the mutations E330 --> M, V331 --> I, D334 --> A, and Y335 --> A.
###end p 17
###begin p 18
###xml 19 20 19 20 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 51 52 47 48 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 314 317 306 309 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 397 399 389 391 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 449 451 441 443 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 501 504 493 496 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 516 519 506 509 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 536 538 524 526 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 588 591 576 579 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 603 606 589 592 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 623 625 607 609 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF</sup>
###xml 675 678 659 662 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 690 693 672 675 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 710 712 690 692 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI</sup>
###xml 762 765 742 745 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 777 780 755 758 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 796 801 772 777 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">I332A</sup>
###xml 850 853 826 829 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 869 874 843 848 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">W333A</sup>
###xml 923 926 897 900 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 943 948 915 920 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 1018 1021 990 993 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 1030 1033 1000 1003 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 1042 1045 1010 1013 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1058 1061 1024 1027 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 1078 1083 1042 1047 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 1153 1156 1117 1120 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 1165 1168 1127 1130 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1177 1180 1137 1140 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1193 1196 1151 1154 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 1213 1218 1169 1174 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 1288 1291 1244 1247 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 1300 1303 1254 1257 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 1312 1315 1264 1267 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1328 1331 1278 1281 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 1348 1353 1296 1301 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 1423 1426 1371 1374 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 1435 1438 1381 1384 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1447 1450 1391 1394 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1463 1466 1405 1408 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 423 428 <span type="species:ncbi:9606">human</span>
###xml 465 470 <span type="species:ncbi:9606">human</span>
###xml 552 557 <span type="species:ncbi:9606">human</span>
###xml 639 644 <span type="species:ncbi:9606">human</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
###xml 815 820 <span type="species:ncbi:9606">human</span>
###xml 888 893 <span type="species:ncbi:9606">human</span>
###xml 982 987 <span type="species:ncbi:9606">human</span>
###xml 1117 1122 <span type="species:ncbi:9606">human</span>
###xml 1252 1257 <span type="species:ncbi:9606">human</span>
###xml 1387 1392 <span type="species:ncbi:9606">human</span>
Abbreviations: PS, l-alpha-phosphatidylserine; PC, l-alpha-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); HPLC, high-performance liquid chromatography; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; [OG488]-EGR-hXa, factor Xa labeled in the active site with Oregon Green 488; factor VaWT, recombinant wild-type human factor Va; factor VaKF, recombinant human factor Va with the mutations D334 --> K and Y335 --> F; factor VaAA, recombinant human factor Va with the mutations D334 --> A and Y335 --> A; factor VaFF, recombinant human factor Va with the mutations E323 --> F and Y324 --> F; factor VaMI, recombinant human factor Va with the mutations E330 --> M and V331 --> I; factor VI332A, recombinant human factor Va with the mutation I332 --> A; factor VW333A, recombinant human factor Va with the mutation W333 --> A; factor VaFF/KF, quadruple mutant of recombinant human factor Va with the mutations E323 --> F, Y324 --> F, D334 --> K, and Y335 --> F; factor VaMI/KF, quadruple mutant of recombinant human factor Va with the mutations E330 --> M, V331 --> I, D334 --> K, and Y335 --> F; factor VaFF/AA, quadruple mutant of recombinant human factor Va with the mutations E323 --> F, Y324 --> F, D334 --> A, and Y335 --> A; factor VaMI/AA, quadruple mutant of recombinant human factor Va with the mutations E330 --> M, V331 --> I, D334 --> A, and Y335 --> A.
###end p 18
###begin title 19
Thrombin Generation Assay Using a Fluorescent Thrombin Inhibitor
###end title 19
###begin p 20
###xml 113 115 113 115 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 197 198 197 198 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 207 209 207 209 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 384 386 379 381 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">ex</sub>
###xml 406 408 396 398 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">em</sub>
###xml 790 799 780 787 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">(DY&#8594;KF)</sup>
###xml 1070 1072 1058 1060 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref30">30</xref>
Thrombin generation assays were performed using the fluorescent thrombin inhibitor DAPA as described previously (23). The buffer used was composed of 20 mM Tris, 0.15 M NaCl (pH 7.4), and 5 mM CaCl2 (TBS, Ca2+) and was made fresh and filtered before each use. Fluorescence was measured on a Perkin-Elmer LS-50B luminescence spectrometer (Perkin-Elmer Corp., Norwalk, CT) with a lambdaex of 280 nm, a lambdaem of 550 nm, and a 500 nm long-pass filter in the emission beam (Schott KV-500). The data points were captured using FL WinLab (Perkin-Elmer Corp.) and subsequently analyzed and plotted using Prizm (GraphPad, San Diego, CA). Peptides AP3 and AP4' were made in the analytical facility of A. Kurosky (University of Texas, Medical Branch, Galveston, TX). Peptides IWDYA, AP5, AP4', AP5m(DY-->KF), AP6, and the control P15H were purchased from New England Peptide (NEP, Gardner, MA). Peptides were dissolved in water or buffer. Accurate peptide concentrations were determined by amino acid composition in the analytical facility of A. Kurosky as detailed previously (30).
###end p 20
###begin title 21
Fluorescence Anisotropy Measurements
###end title 21
###begin p 22
###xml 34 37 34 37 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 175 177 175 177 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 282 284 277 279 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">ex</sub>
###xml 304 306 294 296 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">em</sub>
The fluorescence anisotropy of [OG488]-EGR-hXa was measured using a Perkin-Elmer LS-50B luminescence spectrometer in L-format essentially as extensively described previously (23). Anisotropy measurements were performed in a quartz cuvette under constant stirring (low) with a lambdaex of 490 nm, a lambdaem of 520 nm, and a long-pass filter (Schott KV-520) in the emission beam. All experiments were performed in the dark. The data obtained were instantly analyzed using FL WinLab (Perkin-Elmer Corp.).
###end p 22
###begin title 23
PCR Site-Directed Mutagenesis and Transient Expression of Factor V Molecules
###end title 23
###begin p 24
###xml 8 10 8 10 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 68 69 68 69 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 68 69 68 69 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 70 71 70 71 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 70 71 70 71 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 73 74 73 74 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 73 74 73 74 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 117 118 117 118 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 117 118 117 118 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 120 121 120 121 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 120 121 120 121 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 122 123 122 123 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 122 123 122 123 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 269 271 269 271 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 796 798 796 798 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 856 857 856 857 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 856 857 856 857 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 859 862 859 862 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GCC</bold>
###xml 859 862 859 862 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GCC</bold></underline>
###xml 915 918 915 918 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GGC</bold>
###xml 915 918 915 918 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GGC</bold></underline>
###xml 920 921 920 921 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 920 921 920 921 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 965 970 965 970 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 1035 1038 1035 1038 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG</bold>
###xml 1035 1038 1035 1038 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>ATG</bold></underline>
###xml 1038 1039 1038 1039 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1038 1039 1038 1039 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 1050 1051 1050 1051 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1050 1051 1050 1051 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 1052 1053 1052 1053 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1052 1053 1052 1053 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 1055 1056 1055 1056 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1055 1056 1055 1056 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 1111 1112 1111 1112 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1111 1112 1111 1112 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 1114 1115 1114 1115 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1114 1115 1114 1115 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1116 1117 1116 1117 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1116 1117 1116 1117 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 1128 1129 1128 1129 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1128 1129 1128 1129 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1129 1132 1129 1132 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">CAT</bold>
###xml 1129 1132 1129 1132 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>CAT</bold></underline>
###xml 1183 1188 1183 1188 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 1245 1248 1245 1248 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">TTT</bold>
###xml 1245 1248 1245 1248 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>TTT</bold></underline>
###xml 1250 1251 1250 1251 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1250 1251 1250 1251 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 1289 1290 1289 1290 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1289 1290 1289 1290 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 1291 1292 1291 1292 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1291 1292 1291 1292 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 1294 1295 1294 1295 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1294 1295 1294 1295 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 1350 1351 1350 1351 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1350 1351 1350 1351 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 1353 1354 1353 1354 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1353 1354 1353 1354 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1355 1356 1355 1356 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1355 1356 1355 1356 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 1394 1395 1394 1395 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1394 1395 1394 1395 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 1397 1400 1397 1400 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">AAA</bold>
###xml 1397 1400 1397 1400 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>AAA</bold></underline>
###xml 1443 1448 1443 1448 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 1513 1516 1513 1516 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG</bold>
###xml 1513 1516 1513 1516 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>ATG</bold></underline>
###xml 1516 1517 1516 1517 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1516 1517 1516 1517 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 1529 1530 1529 1530 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1529 1530 1529 1530 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1532 1535 1532 1535 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GCC</bold>
###xml 1532 1535 1532 1535 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GCC</bold></underline>
###xml 1588 1591 1588 1591 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GGC</bold>
###xml 1588 1591 1588 1591 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GGC</bold></underline>
###xml 1593 1594 1593 1594 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1593 1594 1593 1594 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 1606 1607 1606 1607 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1606 1607 1606 1607 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1607 1610 1607 1610 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">CAT</bold>
###xml 1607 1610 1607 1610 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>CAT</bold></underline>
###xml 1661 1666 1661 1666 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 1723 1726 1723 1726 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">TTT</bold>
###xml 1723 1726 1723 1726 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>TTT</bold></underline>
###xml 1728 1729 1728 1729 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1728 1729 1728 1729 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 1768 1769 1768 1769 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1768 1769 1768 1769 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1771 1774 1771 1774 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GCC</bold>
###xml 1771 1774 1771 1774 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GCC</bold></underline>
###xml 1828 1829 1828 1829 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1828 1829 1828 1829 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 1831 1832 1831 1832 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1831 1832 1831 1832 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1833 1834 1833 1834 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1833 1834 1833 1834 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 1873 1874 1873 1874 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1873 1874 1873 1874 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 1874 1877 1874 1877 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">CAT</bold>
###xml 1874 1877 1874 1877 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>CAT</bold></underline>
###xml 1920 1925 1920 1925 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">I332A</sup>
###xml 1982 1984 1982 1984 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</bold>
###xml 1982 1984 1982 1984 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GC</bold></underline>
###xml 2063 2065 2063 2065 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</bold>
###xml 2063 2065 2063 2065 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GC</bold></underline>
###xml 2108 2113 2108 2113 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">W333A</sup>
###xml 2174 2176 2174 2176 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</bold>
###xml 2174 2176 2174 2176 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GC</bold></underline>
###xml 2247 2249 2247 2249 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</bold>
###xml 2247 2249 2247 2249 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GC</bold></underline>
Factor VKF was constructed using the mutagenic primers 5'-C ATT TGG AAG TTT GCA CCT G-3' (forward) and 5'-C AGG TGC AAA CTT CCA AAT G-3' (reverse) (bold underlined letters identify the mutated bases) in a two-stage PCR method and characterized as previously described (29). The resulting amplicon was subcloned into pGEM-T, and the mutations were confirmed by DNA sequencing (DNA Analysis Facility, Cleveland State University). The pGEM-T plasmid was digested with restriction enzymes Bsu36I and XcmI to remove the factor V insert, and the insert containing the mutation was ligated into pMT2-FV at the same restriction sites. The remaining recombinant plasmids were constructed using Stratagene's QuikChange XL site-directed mutagenesis kit according to the manufacturer's instructions. Factor VAA was constructed with the primers 5'-GAG GAA GTC ATT TGG GCC GCC GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC GGC GGC CCA AAT GAC TTC CTC-3' (reverse). Factor VMI/KF was constructed with the primers 5'-GAA TAC TTC ATT GCT GCA GAG ATGGTC ATT TGG AAG TTT GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC AAA CTT CCA AAT GACCAT CTC TGC AGC AAT GAA GTA TTC-3' (reverse). Factor VFF/KF was constructed with the primers 5'-CAC ATG AAG ATT TGG TTT TTC TTC ATT GCT GCA GAG GAA GTC ATT TGG AAG TTT GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC AAA CTT CCA AAT GAC TTC CTC TGC AGC AAT GAA GAA AAA CCA AAT CTT CAT GTG-3' (reverse). Factor VMI/AA was constructed with the primers 5'-GAA TAC TTC ATT GCT GCA GAG ATGGTC ATT TGG GCC GCC GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC GGC GGC CCA AAT GACCAT CTC TGC AGC AAT GAA GTA TTC-3' (reverse). Factor VFF/AA was constructed with the primers 5'-CAC ATG AAG ATT TGG TTT TTC TTC ATT GCT GCA GAG GAA GTC ATT TGG GCC GCC GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC AAA CTT CCA AAT GAC TTC CTC TGC AGC AAT GAA GACCAT CCA AAT CTT CAT GTG-3' (reverse). Factor VI332A was constructed with the primers 5'-GCT GCA GAG GAA GTC GCT TGG GAC TAT GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC ATA GTC CCA AGC GAC TTC CTC TGC AGC-3' (reverse). Factor VW333A was constructed with the primers 5'-GCT GCA GAG GAA GTC ATT GCG GAC TAT GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC ATA GTC CGC AAT GAC TTC CTC TGC AGC-3' (reverse). In all the primers, the bases that are bold and underlined represent the mismatch. The mutations were confirmed by DNA sequencing (DNA Analysis Facility, Cleveland State University).
###end p 24
###begin title 25
Transfection of Recombinant Factor V Molecules into COS-7L Cells
###end title 25
###begin p 26
###xml 223 224 219 220 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 395 397 385 387 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 398 400 388 390 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 109 115 <span type="species:ncbi:9913">bovine</span>
The COS-7L cell line was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and the antibiotics streptomycin (100 microg/mL) and penicillin (100 IU/mL) in an atmosphere of 5% CO2 and 95% air at 37 degreesC. The purified wild-type and mutated plasmids were transfected into the COS-7L cells with Fugene 6 (Roche Diagnostics) as described previously (29,31).
###end p 26
###begin title 27
Purification of Recombinant Proteins
###end title 27
###begin p 28
###xml 114 116 114 116 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 126 128 126 128 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 138 143 138 143 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">I332A</sup>
###xml 153 158 153 158 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">W333A</sup>
###xml 172 174 172 174 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 237 239 237 239 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref32">32</xref>
###xml 313 315 313 315 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 336 338 336 338 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 414 416 414 416 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 417 419 417 419 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 496 498 496 498 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 499 501 499 501 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 585 587 585 587 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref32">32</xref>
###xml 628 629 628 629 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
The medium containing the recombinant proteins was centrifuged to remove any cellular debris. Recombinant factor VKF, factor VAA, factor VI332A, factor VW333A, and factor VWT were purified and quantified as recently described in detail (32). In some instances, the quadruple recombinant factor V mutants, factor VKF, as well as factor VWT were partially purified and quantified as extensively detailed previously (29,31). The activities of the partially purified recombinant factor Va molecules (29,31) and the activities of the recombinant cofactor molecules purified to homogeneity (32) were similar and are reported in Table 1. The proteins were stored at -80 degreesC in small aliquots to prevent repeated freeze-thaw cycles. The activity and integrity of the recombinant factor V molecules were confirmed by clotting assays using factor V-deficient plasma and Western blotting with monoclonal and polyclonal antibodies.
###end p 28
###begin title 29
Functional Properties of Recombinant Factor Va Molecules
###end title 29
###begin p 30
###xml 90 90 90 90 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
Two-stage clotting assays of recombinant factor V molecules was performed as described in .
###end p 30
###begin p 31
###xml 87 88 87 88 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 88 92 88 92 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">Dapp</sub>
###xml 126 126 126 126 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
Apparent dissociation constants of recombinant factor Va for plasma-derived factor Xa (KDapp) were determined as described in  at limiting factor Xa concentrations (15 pM).
###end p 31
###begin p 32
###xml 9 10 9 10 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 10 11 10 11 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 16 17 16 17 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 17 20 17 20 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 38 39 38 39 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 81 81 81 81 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
Apparent Km and kcat (shown in Figure 5B) values were determined as described in  at limiting factor Xa concentrations (5 pM) and saturating concentrations of factor Va.
###end p 32
###begin p 33
###xml 93 95 93 95 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
The recombinant molecules were partially purified and assayed as described in detail in ref (29).
###end p 33
###begin p 34
###xml 59 61 59 61 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
The recombinant molecules were fully characterized in ref (31).
###end p 34
###begin title 35
Prothrombin Activation Analysis by Gel Electrophoresis
###end title 35
###begin p 36
###xml 226 228 214 216 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 456 458 444 446 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
Prothrombin (1.4 microM) was incubated in a reaction mixture containing 20 microM PCPS, 50 microM DAPA, and various recombinant factor Va molecules at 10 nM (activated with thrombin at a 1/50 enzyme/substrate ratio) in TBS, Ca2+. The addition of factor Xa (1 nM) marked the start of the reaction. Aliquots of the reaction mixture were removed at selected time points and added to 2 volumes of 0.2 M glacial acetic acid and treated as described previously (31). The dried samples were reconstituted in 0.1 M Tris base (pH 6.8), 1% SDS, and 1% beta-mercaptoethanol and heated for 75 s at 95 degreesC. A total of 5 microg of total protein was loaded per lane and analyzed via 9.5% SDS-PAGE.
###end p 36
###begin title 37
Gel Electrophoresis and Western Blotting
###end title 37
###begin p 38
###xml 206 208 203 205 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref33">33</xref>
###xml 325 327 322 324 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref34">34</xref>
###xml 749 751 746 748 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref30">30</xref>
###xml 752 754 749 751 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analyses were carried out using 9.5% or 4 to 12% gradient gels following reduction with 2% beta-mercaptoethanol as described previously (33). In some cases, the protein was transferred to polyvinylidene difluoride (PVDF) membranes as described previously (34). Factor Va heavy and light chains were probed with the appropriate monoclonal antibodies and visualized with chemiluminescence, or the protein was visualized by staining with Coomassie Brilliant Blue R-250, followed by destaining in a solution of methanol, acetic acid, and water. In some experiments, gels were analyzed by scanning densitometry using UN-SCAN-IT gel (Silk Scientific, Orem, UT) as described previously (30,31).
###end p 38
###begin title 39
Assay Measuring Thrombin Formation
###end title 39
###begin p 40
###xml 161 163 161 163 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 316 318 310 312 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref35">35</xref>
###xml 513 514 499 500 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The ability of the recombinant factor V molecules to assemble in the prothrombinase complex was assessed in a discontinuous assay described in detail elsewhere (31). In short, all recombinant factor V molecules were activated with thrombin (1/50 enzyme/substrate ratio, 10 min at 37 degreesC) as described recently (35). Reaction mixtures contained PCPS vesicles (20 microM), DAPA (3 microM), factor Xa (varying concentrations), and recombinant factor Va species in reaction buffer [HEPES, 0.15 M NaCl, 50 nM CaCl2, and 0.01% Tween 20 (pH 7.40)]. DAPA (at twice the concentration of prothrombin) was included in all mixtures to prevent the action of thrombin during the course of the assay on factor Va, on prothrombin, and on itself. The rate of thrombin generation was subsequently measured using an excess of chromogenic substrate, Spectrozyme-TH (0.4 mM). The initial rate of thrombin generation was analyzed with Prizm (GraphPad), and kinetic constants were extracted directly from the graphs.
###end p 40
###begin p 41
###xml 27 28 27 28 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 28 29 28 29 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 322 323 322 323 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 323 324 323 324 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 329 330 329 330 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 330 333 330 333 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 632 637 632 637 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 647 652 647 652 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 662 667 662 667 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 681 686 681 686 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 892 893 888 889 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="eq1" ref-type="disp-formula">1</xref>
###xml 924 926 920 922 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref36">36</xref>
###xml 927 929 923 925 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref37">37</xref>
###xml 959 960 955 956 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 969 970 965 966 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1078 1079 1074 1075 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1079 1080 1075 1076 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 1274 1275 1270 1271 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
For the calculation of the KD between the factor Va molecules and factor Xa, assays were performed in the presence of a limiting factor Xa concentration (15 pM) and varying concentrations of the recombinant factor Va species (from 25 pM to 5 nM). For the determination of the kinetic constants of prothrombinase assembly, Km and kcat, experiments were executed with a limiting amount of factor Xa (5 pM) in the presence of a fixed amount of the various recombinant factor Va molecules (10 nM) and a varied amount of substrate (prothrombin). Experiments performed with the quadruple mutants used saturating concentrations of factor VFF/KF, factor VMI/KF, factor VFF/AA, and factor VMI/AA and varying amounts of the substrate prothrombin (from 25 nM to 4 microM). The concentration of each mutant cofactor molecule necessary to saturate factor Xa was calculated with the quadratic equation (eq 1) described in the literature (36,37) and given below.  where [Va]T and [Xa]T are the total concentrations of factor Va and factor Xa, respectively. The apparent dissociation constant (KD) for the bimolecular interaction between factor Va and factor Xa on a phospholipid surface was obtained from the functional titration described above and the total concentration of ligand ([Va]T) modified as appropriate.
###end p 41
###begin title 42
Additive Effect of the Mutations on Prothrombinase Function
###end title 42
###begin p 43
###xml 265 267 265 267 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref38">38</xref>
###xml 268 270 268 270 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref42">42</xref>
###xml 287 289 287 289 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 720 721 712 713 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 721 722 713 714 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
###xml 721 722 713 714 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#10727;</sup></sup>
###xml 722 727 714 717 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8594;B</sub>
###xml 835 836 825 826 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 875 877 865 867 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 881 883 871 873 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 886 887 876 877 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 959 960 949 950 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 960 963 950 953 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 992 993 982 983 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 993 994 983 984 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1110 1111 1092 1093 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1111 1114 1093 1096 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sub>
The change in transition-state stabilization free energy, which measures the effect that mutations in the cofactor of the prothrombinase complex have on the catalytic site of the enzyme, was calculated for the quadruple mutants as extensively described previously (38-42), and recently (31). In brief, the perturbation to the function of prothrombinase assembled with wild-type factor Va (state A) caused by a mutation in factor Va (state B) affecting the transition state can be defined in general as follows:  Since prothrombinase activity (assembled with each of the recombinant factor Va proteins) is being measured against the same substrate (prothrombin), the transition-state stabilization free energy (DeltaDeltaGA-->B) during catalysis induced by a mutation in factor Va can be determined from the following equation:  where R is the universal gas constant (2 cal K-1 mol-1), T is the absolute temperature (298 K in the experiments presented here), kcat is the turnover number, and Km is the Michaelis-Menten constant of the reaction. Once calculated, these values can be used to determine DeltaDeltaGint, which reflects the exchange in free energy between the amino acid side chains manipulated in this study (E323F, Y324F, E330M, V331I, D334K, Y335F, D334A, and Y335A) by the following equation:
###end p 43
###begin p 44
###xml 30 31 22 23 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 31 34 23 26 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sub>
A positive value of DeltaDeltaGint indicates that the interaction of these amino acid side chains reduces the catalytic efficiency of prothrombinase, while a negative value demonstrates that the mutations are better for prothrombinase, resulting in an increase in the catalytic efficiency of the enzyme. A value of zero would indicate no effect.
###end p 44
###begin title 45
Molecular Dynamics Simulation Setup
###end title 45
###begin p 46
###xml 9 11 9 11 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 25 27 25 27 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 88 90 88 90 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref19">19</xref>
###xml 125 128 125 128 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 136 139 136 139 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 317 319 317 319 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref43">43</xref>
###xml 690 692 690 692 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref44">44</xref>
###xml 693 695 693 695 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref45">45</xref>
###xml 749 751 749 751 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref46">46</xref>
###xml 864 866 864 866 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref47">47</xref>
###xml 932 934 932 934 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 1059 1061 1059 1061 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref48">48</xref>
###xml 1268 1270 1268 1270 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref49">49</xref>
###xml 1271 1273 1271 1273 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref50">50</xref>
###xml 1636 1638 1636 1638 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref51">51</xref>
###xml 1826 1828 1826 1828 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1832 1834 1832 1834 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1834 1836 1834 1836 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref52">52</xref>
###xml 1834 1836 1834 1836 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref52">52</xref></sup>
###xml 2187 2189 2187 2189 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref44">44</xref>
###xml 2190 2192 2190 2192 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref45">45</xref>
Factor VaKF and factor VaAA were modeled using the recent factor Va model (PDB entry ) (19). Briefly, amino acid residues Asp334 and Tyr335 were substituted with both lysine and phenylalanine, respectively, or with alanine. The amino acid change was performed using the "mutate" tool from the SwissPDBViewer package (43). Wild-type factor Va was left unchanged. The molecular dynamics simulation of each factor Va model consisted of a three-step setup: (1) the solvation of the protein followed by energy minimization, (2) position restraint molecular dynamics simulation, and (3) production run molecular dynamics simulation. Simulations were run and analyzed using GROMACS version 3.2.1 (44,45). The system was solvated using the SPC water model (46). The force used to describe the interaction parameters was set to GROMOS-87 implemented in GROMACS as "ffgmx" (47). Molecular topologies for both wild-type factor Va and factor VaKF were generated using the atom types described in the "ffgmx" force field. Bonds were constrained using the LINCS algorithm (48). Long-range electrostatic interactions were evaluated with the particle mesh Ewald summation method performed in all three dimensions and using a fourth-order Fourier interpolation on a 1.6 A spaced grid (49,50). Following the minimization procedure, the systems were subjected to a 20 ps molecular dynamics simulation with the restriction that only water molecules were allowed to move freely and the protein was restrained. The simulation temperature was set to 300 K and was maintained using the Berendsen temperature coupling with the coupling parameter set to 0.1 ps (51). The constant reference pressure of 1 bar was maintained throughout the simulation using the Parrinello-Rahman isotropic pressure coupling scheme with the compressibility set to 4.5 x 10-5 bar-152. Simulations were run until the systems reached equilibrium. Equilibration of each system was confirmed when the root-mean-square displacement of the protein reached a plateau and the drift was less than 1 A during a whole nanosecond simulation time. The last nanosecond of the equilibrated trajectories was analyzed using tools included in GROMACS (44,45).
###end p 46
###begin title 47
Results
###end title 47
###begin title 48
Inhibition of Prothrombinase Function by Synthetic Peptides from the Central Portion of the Factor Va Heavy Chain
###end title 48
###begin p 49
###xml 119 121 119 121 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 231 233 231 233 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 681 684 681 684 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 689 692 689 692 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">336</sup>
###xml 951 952 951 952 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">2</xref>
###xml 1119 1120 1119 1120 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 1188 1190 1188 1190 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1225 1226 1209 1210 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 1346 1347 1330 1331 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 1506 1507 1482 1483 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1507 1508 1483 1484 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1575 1577 1551 1553 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1799 1802 1771 1774 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 1934 1937 1902 1905 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 1955 1956 1923 1924 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 2029 2030 1997 1998 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 2104 2107 2072 2075 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 2142 2144 2110 2112 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 2184 2185 2152 2153 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2270 2273 2238 2241 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 2291 2292 2259 2260 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 2459 2461 2427 2429 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 2562 2563 2530 2531 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 2563 2564 2531 2532 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 2608 2609 2574 2575 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 2609 2612 2575 2578 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 2747 2748 2713 2714 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 2748 2749 2714 2715 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
We have previously shown that a peptide representing amino acid residues 323-331 inhibits factor Va cofactor activity (23). We have extensively characterized the important amino acids from this region by site-directed mutagenesis (29). We have also shown that under our experimental conditions, peptides encompassing residues 327-336 (AP5) and 332-341 (AP6) of the factor Va heavy chain also inhibit factor Va cofactor activity, while the pentadecapeptide P15H (representing amino acids 337-351 of factor V) did not have any effect on factor Va activity and was a good negative control. We have thus hypothesized that the overlapping sequence between AP5 and AP6 (amino acid motif 332IWDYA336) may contain amino acids responsible for the inhibition of prothrombinase. To investigate the role of these amino acids as it pertains to prothrombinase assembly and function, we have initiated a series of experiments using peptides from this region (Figure 2). The peptides were assayed for their ability to inhibit prothrombinase activity in an assay that uses purified reagents and a fluorescent thrombin inhibitor (Figure 3A). The data demonstrate that AP5 inhibits prothrombinase with an IC50 of approximately11 microM [Figure 3A ()], while the control peptide (P15H) had no effect on prothrombinase activity under the conditions employed [Figure 3A ()], even at concentrations as high as 500 microM (not shown). Complete inhibition of prothrombinase by AP5 occurred at 200 microM peptide (not shown). The Ki for the inhibition of prothrombinase by AP5 calculated from the IC50 was found to be 5.9 microM. This constant represents the dissociation constant of AP5 for prothrombinase. We have also assessed the effect of AP5 and AP6 for their ability to inhibit the direct binding of factor Va to [OG488]-EGR-hXa. Both peptides at concentrations as high as 100 microM were unable to inhibit the direct interaction of factor Va with [OG488]-EGR-hXa [Figure 3B ( and , respectively)]. In contrast, the nonapeptide control [Figure 3B, AP4' ()] was a good inhibitor of the interaction of factor Va with [OG488]-EGR-hXa as previously described (23). In addition, AP3 that contains the NH2-terminal portion of AP4' also inhibited the direct interaction of factor Va with [OG488]-EGR-hXa [Figure 3B ()], albeit less efficiently than AP4'. It is noteworthy that AP3 is a noncompetitive inhibitor of prothrombinase (Figure S1) with respect to substrate, like AP4' (23). Kinetic analyses demonstrated that in the presence of increasing concentrations of inhibitor, the Km remained constant (0.4 +/- 0.06) while the Vmax of the enzymatic reaction decreased (Figure S1A). Using the mathematical transformation associated with the Dixon plots, the apparent Ki of prothrombinase with AP3 was found to be approximately15.6 microM (Figure S1B). Finally, it is important to underline that control experiments demonstrated that AP5 did not have any effect on the catalytic activity of factor Xa, since high concentrations of peptide were unable to inhibit factor Xa activity toward both a chromogenic substrate and prothrombin (data not shown).
###end p 49
###begin p 50
###xml 115 116 115 116 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">1</xref>
###xml 322 324 322 324 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 418 421 418 421 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 425 428 425 428 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
Factor Va heavy chain peptides. At the top, the sequence of N42R is illustrated (part of the hatched box in Figure 1). The underlined sequence (323-335, 13 amino acids) is the regulatory amino acid sequence of the factor Va heavy chain. Overlapping peptides from the central portion of the factor Va heavy chain [AP3-AP7 (23)] are also shown. The role of the underlined amino acid region included in the box (i.e., Arg334-Tyr335) and common to IWDYA, AP5 and AP6, is under investigation here. Bold and underlined residues are the amino acid residues mutated in this study.
###end p 50
###begin p 51
###xml 158 165 158 163 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">DY&#8594;KF</sup>
###xml 255 255 253 253 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 375 376 373 374 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">2</xref>
###xml 447 454 445 450 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">DY&#8594;KF</sup>
###xml 744 745 725 726 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 937 938 918 919 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 938 939 919 920 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1005 1007 986 988 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1010 1011 991 992 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1011 1012 992 993 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1017 1018 998 999 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 1018 1019 999 1000 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1020 1021 1001 1002 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1021 1022 1002 1003 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1025 1027 1006 1008 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref53">53</xref>
###xml 1036 1037 1017 1018 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1037 1038 1018 1019 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1117 1118 1098 1099 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 1118 1119 1099 1100 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1168 1170 1149 1151 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1320 1323 1301 1304 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sub>
###xml 1458 1460 1435 1437 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1619 1620 1592 1593 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1652 1652 1625 1625 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 1701 1703 1674 1676 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 335 340 <span type="species:ncbi:9606">human</span>
###xml 642 647 <span type="species:ncbi:9606">human</span>
###xml 1402 1407 <span type="species:ncbi:9606">human</span>
Inhibitory potential of factor Va heavy chain peptides. (A) Inhibition of prothrombinase activity. Increasing concentrations of AP5, AP6, P15H, IWDYA, and AP5DY-->KF were preincubated with factor Xa and assayed for prothrombinase activity as described in . P15H () represents the control peptide containing amino acids 337-351 of the human factor Va heavy chain (see Figure 2 for details). AP5 () represents amino acids 327-336 of factor Va. AP5DY-->KF (big up tri, open) represents amino acid residues 327-336 with residues 334 and 335 mutated from D and Y to K and F, respectively. IWDYA () represents amino acid residues 332-336 of the human factor Va heavy chain. Data for AP6 are shown with . The concentration of peptide given on the x axis represents its final concentration in the prothrombinase mixture. The data represent the average of the results found in three independent experiments. The apparent inhibition constant (Ki) reported in the text is the value calculated from the formula IC50 = Ki(1 + S0/Km) (53), where Km is the Michaelis-Menten constant of the reaction in the absence of inhibitor, S0 is the concentration of prothrombin used, and IC50 is the half-maximal inhibition of prothrombinase by a given peptide. (B) Inhibition of prothrombinase assembly. Prothrombinase was assembled with [OG488]-EGR-hXa (10 nM), PCPS vesicles (10 microM), and increasing concentrations of human factor Va (up to 25 nM) in the presence of 2 mM Ca2+. Once a plateau was obtained, the preformed complexes were titrated with increasing concentrations of P15H (), AP3 (), AP4' (), AP5 (), and AP6 (). Deltar was calculated as described in  and plotted as extensively detailed previously (23). The data represent all the data points from two independent experiments performed in triplicate.
###end p 51
###begin p 52
###xml 181 182 181 182 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 182 183 182 183 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 188 189 188 189 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 189 192 189 192 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 261 262 261 262 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 340 341 340 341 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 341 342 341 342 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 347 348 347 348 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 348 351 348 351 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 387 388 387 388 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 388 391 388 391 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 410 411 410 411 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 411 412 411 412 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 421 422 421 422 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 585 586 585 586 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 603 604 603 604 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 604 605 604 605 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 676 677 672 673 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 716 717 712 713 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 717 718 713 714 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 745 747 741 743 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1038 1040 1030 1032 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref53">53</xref>
The mechanism of prothrombinase inhibition by AP5 was further investigated by examining the effect of the peptide on the kinetic parameters of prothrombinase assembly and function (Km and Vmax) in the presence of varying concentrations of the inhibitor (Figure 4). In the presence of increasing concentrations of peptide, both the apparent Km and Vmax changed; the inhibitor lowered the Vmax and increased the Km (Figure 4A). Analysis of the kinetic data using the Dixon plots demonstrated that AP5 inhibition of prothrombinase followed a model of linear mixed-type inhibition (Figure 4B). The apparent Ki of prothrombinase extrapolated from the graph was 10.5 microM (Figure 4B) which is in good agreement with the Ki value obtained from the IC50 value determined above (5.9 microM). The inhibition model of a mixed-type inhibitor is defined as unequal binding of the inhibitor to E and ES and suggests that AP5 that contains a portion of the factor Xa binding site may also interact with prothrombin in association with prothrombinase (53). However, it is also possible that binding of prothrombin to prothrombinase alters the affinity of AP5 for the enzyme.
###end p 52
###begin p 53
###xml 211 212 211 212 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 364 366 360 362 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 404 405 396 397 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 405 406 397 398 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 448 449 436 437 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 465 467 453 455 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 514 515 486 487 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 515 516 487 488 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 543 544 511 512 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 544 545 512 513 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 677 680 645 648 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 685 688 653 656 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">336</sup>
###xml 697 698 665 666 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">2</xref>
###xml 784 785 752 753 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 828 829 796 797 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 829 830 797 798 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 989 990 941 942 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 990 991 942 943 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1069 1070 1005 1006 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1249 1252 1185 1188 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">227</sup>
###xml 1257 1260 1193 1196 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1297 1299 1233 1235 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 1392 1395 1328 1331 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 1403 1406 1339 1342 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1472 1474 1408 1410 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
In view of these results, we have synthesized an additional peptide (IWDYA) and assayed its ability to inhibit prothrombinase activity. Peptide IWDYA inhibited cofactor activity, although not completely [Figure 3A ()]. Even at 500 microM peptide there was still approximately 25% cofactor activity remaining (not shown). The data demonstrated that IWDYA has an IC50 of 130 microM which corresponds to a Ki of 69 microM. Interestingly, AP6 [Figure 3A ()] has an IC50 of approximately120 microM corresponding to a Ki of 64 microM. The similar Ki values between AP6 and IWDYA suggest that the inhibitory effect of the peptides is a consequence of the shared amino acid sequence 332IWDYA336 [Figure 2 (boxed sequence)]. However, it is important to note that the data provided in Figure 3A also demonstrate that while AP6 yields a Ki value similar to that of pentapeptide IWDYA for prothrombinase inhibition (approximately60 microM), AP5 which also shares this sequence shows a 10-fold lower Ki value (approximately6 microM). These data suggest that amino acid residues NH2-terminal to pentapeptide IWDYA are functionally important. This conclusion is strengthened by our earlier findings demonstrating the important contribution of amino acid stretch 227AAEEV331 to factor Va-factor Xa interaction (29). More recently, we have provided strong evidence supporting the notion that amino acids Glu330 and Val331 are significant contributors to prothrombinase complex function (31).
###end p 53
###begin p 54
###xml 160 167 160 165 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">DY&#8594;KF</sup>
###xml 418 421 416 419 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 422 425 420 423 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 659 660 641 642 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 690 691 657 658 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 691 692 658 659 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 741 743 692 694 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1218 1219 1157 1158 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">2</xref>
To identify the important amino acid residues of this region for cofactor activity, we have synthesized another peptide with the sequence DY replaced by KF (AP5DY-->KF, AP5m) and assayed the peptide for prothrombinase inhibition. We have arbitrarily chosen to mutate these two amino acids because they are the only charged amino acid residues of this pentapeptide. However, the function of the other two amino acids (I332W333) was also established using recombinant technology and shown below. AP5m had an only weak effect on prothrombinase function with approximately60% cofactor activity remaining at concentrations of peptide as high as 500 microM [Figure 3A (big up tri, open)], with a Ki value of approximately530 microM (assuming an IC50 of approximately1 mM). These data indicate that amino acid region 334-335 is important for the expression of the inhibitory potential of AP5. Taken together, the results indicate that (1) peptide AP5 from the central portion of the factor Va heavy chain is a potent inhibitor of factor Va cofactor activity and (2) amino acid region 323-335 (13 amino acids) from the factor Va heavy chain plays an important role in the optimal expression of prothrombinase activity (Figure 2).
###end p 54
###begin title 55
###xml 41 46 <span type="species:ncbi:9606">Human</span>
Expression and Activation of Recombinant Human Factor V Molecules
###end title 55
###begin p 56
###xml 272 274 272 274 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 347 349 347 349 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 528 533 528 533 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 543 548 543 548 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 558 563 558 563 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 577 582 577 582 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 595 596 595 596 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">1</xref>
###xml 616 618 616 618 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 700 703 700 703 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 709 712 709 712 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 836 841 836 841 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">I332A</sup>
###xml 854 859 854 859 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">W333A</sup>
###xml 942 944 942 944 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1053 1054 1053 1054 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 1065 1067 1065 1067 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1169 1171 1169 1171 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 1185 1187 1185 1187 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 1399 1401 1397 1399 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF</sup>
###xml 1415 1417 1413 1415 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI</sup>
###xml 1468 1470 1466 1468 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 1522 1523 1520 1521 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 2004 2007 2002 2005 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 2013 2016 2011 2014 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
We next employed a recombinant protein scheme to further asses the importance of amino acid region 334-335 of the factor Va heavy chain for cofactor activity. We used one charge reversal mutation (D334K) and one conservative mutation (Y335F) to obtain recombinant factor VKF. We have also replaced both amino acids with alanine to produce factor VAA. In addition, we have combined these mutations with mutations at the extremities of the factor Xa binding site on factor Va. We have thus obtained the quadruple mutants, factor VMI/KF, factor VFF/KF, factor VMI/AA, and factor VFF/AA (see Figure 1 for more details) (31). To assess the importance of the other two amino acids of peptide IWDYA, i.e., I332 and W333, for cofactor function, we have created two additional mutant molecules with these amino acids changed to alanine (factor VI332A and factor VW333A). All eight recombinant factor V molecules along with wild-type factor V (factor VWT) were expressed, purified, and assayed in a two-stage clotting assay, and the results are reported in Table 1. Factor VaWT displayed normal clotting activity, compared to plasma-derived factor Va. Conversely, while factor VaKF and factor VaAA had 5-fold reduced clotting activity under similar experimental conditions, all the quadruple mutants were practically devoid of clotting activity (</=30 units/mg). We have previously demonstrated that factor VaFF and factor VaMI are impaired in their interaction with factor Xa (31). Results with these mutants are reported in Table 1 for comparison. The data demonstrate that while mutation of amino acid region 334-335 impair clotting activity, these mutations alone are not enough to completely abolish factor Va clotting activity. However, combining these mutations with mutations at the extremities of the previously described factor Xa binding site results in cofactor molecules that are devoid of clotting activity. The clotting data obtained with the recombinant proteins also demonstrate that amino acids I332 and W333 are not essential for expression of factor Va clotting activity as the mutant molecules have clotting capabilities comparable to that of the wild-type molecule.
###end p 56
###begin title 57
Effect of Recombinant Factor Va Molecules on Prothrombin Activation by Prothrombinase
###end title 57
###begin p 58
###xml 198 200 198 200 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 305 308 305 308 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">320</sup>
###xml 476 478 476 478 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 491 493 491 493 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 700 705 700 705 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 716 721 716 721 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 732 737 732 737 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 752 757 752 757 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 1064 1066 1064 1066 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 1079 1081 1079 1081 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
The capability of the recombinant factor Va molecules to be incorporated into prothrombinase and activate prothrombin was investigated by gel electrophoresis. Prothrombinase assembled with factor VaWT displayed normal activation pattern compared to the plasma-derived cofactor with initial cleavage at Arg320 producing fragment 1.2-A (Figure S2), indicative of meizothrombin generation. Activation of prothrombin by prothrombinase assembled with recombinant purified factor VaKF or factor VaAA showed delayed thrombin formation as evidenced by delayed formation of both fragment 1.2-A and B chain of thrombin (Figure S2). Under similar experimental conditions, prothrombinase assembled with factor VaFF/KF, factor VaMI/KF, factor VaFF/AA, and factor VaMI/AA did not activate prothrombin to any significant extent, following a 3 h incubation period (data not shown). These results indicate that substitution of amino acids 334 and 335 of the factor Va heavy chain results in delayed prothrombin activation by factor Xa within prothrombinase assembled with factor VaKF or factor VaAA.
###end p 58
###begin title 59
Kinetic Analyses of Prothrombinase Assembled with Recombinant Factor Va
###end title 59
###begin p 60
###xml 199 204 199 204 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">I332A</sup>
###xml 215 220 215 220 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">W333A</sup>
###xml 231 233 231 233 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 248 250 248 250 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 261 262 261 262 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 262 263 262 263 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 339 340 339 340 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 382 387 382 387 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 398 403 398 403 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 414 419 414 419 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 434 439 434 439 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 522 524 522 524 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 546 547 546 547 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
The ability of the recombinant factor Va molecules to be incorporated into prothrombinase was investigated using an assay employing purified reagents. Under similar experimental conditions, factor VaI332A, factor VaW333A, factor VaKF, and factor VaAA displayed KD values comparable to the value obtained with the wild-type molecule (Table 1). Conversely, the affinities of factor VaFF/KF, factor VaFF/AA, factor VaMI/KF, and factor VaMI/AA were 6-, 10-, 23-, and 20-fold, respectively, lower than the affinity of factor VaWT for factor Xa (Table 1). These data demonstrate that amino acids 332-335 do not participate in the interaction of the cofactor with factor Xa.
###end p 60
###begin p 61
###xml 7 8 7 8 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 19 20 19 20 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 56 57 56 57 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 74 75 74 75 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 75 78 75 78 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 87 88 87 88 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 105 106 105 106 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 106 107 106 107 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 115 116 115 116 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 163 164 163 164 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 249 250 249 250 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 250 251 250 251 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 302 303 302 303 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 411 412 411 412 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="eq1" ref-type="disp-formula">1</xref>
###xml 443 445 443 445 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref36">36</xref>
###xml 446 448 446 448 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref37">37</xref>
###xml 466 466 466 466 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 844 846 844 846 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 860 862 860 862 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 956 957 944 945 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 1013 1015 1001 1003 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1088 1093 1076 1081 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/KF</sup>
###xml 1104 1109 1092 1097 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/KF</sup>
###xml 1120 1125 1108 1113 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI/AA</sup>
###xml 1140 1145 1128 1133 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF/AA</sup>
###xml 1190 1191 1178 1179 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1191 1194 1179 1182 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 1277 1278 1265 1266 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 1374 1377 1362 1365 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">332</sup>
###xml 1383 1386 1371 1374 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
Figure 5 and Table 1 show the original raw data (Figure 5A), the apparent kcat (Figure 5B), the apparent Km (Table 1), and the second-order rate constants (Figure 5C) of prothrombinase assembled with the recombinant factor Va molecules. Knowing the KD of each recombinant molecule for factor Xa (Table 1), we calculated the appropriate amount of factor Va to saturate factor Xa using the quadratic equation (eq 1) described in the literature (36,37) and provided in . Thus, the titrations were performed under conditions where all factor Xa was saturated with factor Va, and as a consequence, any observed deficiency in the catalytic activity of prothrombinase was attributed to a defective factor Va molecule rather than to an impaired factor Va-factor Xa interaction. The data demonstrate that prothrombinase assembled with purified factor VaKF and factor VaAA was characterized by an approximately10-fold decrease in second-order rate constants (Figure 5B,C) compared to prothrombinase assembled with factor VaWT. Prothrombinase assembled with the quadruple mutant molecules, factor VaMI/KF, factor VaFF/KF, factor VaMI/AA, and factor VaFF/AA, demonstrated a significant decrease in the kcat and the second-order rate constant of the enzyme [up to 400-fold decrease (Figure 5C)]. The kinetic data obtained with the recombinant proteins also demonstrate that amino acids I332 and W333 are not required for expression of factor Va cofactor activity since the kinetic constants obtained with prothrombinase assembled with these two mutant molecules are similar to the data obtained with prothrombinase assembled with wild-type factor Va. Overall, the data show that substitution of amino acids 334 and 335 in factor Va has an effect on the catalytic efficiency of prothrombinase.
###end p 61
###begin p 62
###xml 284 284 280 280 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 528 529 520 521 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 529 530 521 522 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 637 638 629 630 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 638 639 630 631 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 752 754 744 746 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref53">53</xref>
###xml 791 792 783 784 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 792 793 784 785 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 977 978 953 954 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 978 979 954 955 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Kinetic analyses of prothrombin activation by prothrombinase in the presence of AP5. (A) Michaelis-Menten plots. Prothrombin generation experiments were performed in the absence () and presence of increasing concentrations of AP5 [10 (), 15 (), and 20 microM ()], as described in  using prothrombin concentrations varying from 40 nM to 1 microM. Initial rates of thrombin formation are plotted as a function of substrate concentration. (B) Analysis of the data using the Dixon plots. The data were analyzed and plotted as 1/Vo as a function of inhibitor concentration (AP5, Dixon plots). For mixed-type inhibition, a Dixon plot of 1/Vo as a function of increasing concentration of inhibitor is linear at a fixed enzyme and substrate concentration (53). The apparent inhibition constant (Ki) reported in the text is the value derived from the intercept of each of the four graphs (approximately10.5 microM). The lines drawn represent the best fit through the points with an R2 varying from 0.9812 (worst) to 0.9881 (best). The following concentrations of prothrombin were used in the experiments: 80 (), 100 (), 150 (), and 200 nM (big up tri, open).
###end p 62
###begin p 63
###xml 200 200 200 200 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 363 365 363 365 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 380 385 380 385 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF-KF</sup>
###xml 451 453 436 438 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 480 485 465 470 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI-AA</sup>
###xml 500 505 485 490 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI-KF</sup>
###xml 520 525 505 510 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF-AA</sup>
###xml 540 545 525 530 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">I332A</sup>
###xml 564 569 549 554 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">W333A</sup>
###xml 575 576 560 561 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 576 577 561 562 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 631 632 616 617 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 644 645 629 630 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 645 648 630 633 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 681 683 666 668 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 737 739 722 724 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 741 743 726 728 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Prothrombin titrations to determine the kinetic parameters of prothrombinase assembled with the various recombinant factor Va species. Thrombin generation experiments were carried out as described in  by varying the substrate concentration. The raw data (hyperbolas) are shown in panel A: ( and ) two different preparations of wild-type factor Va, (o) factor VaAA, () factor VaFF-KF, (big dn tri, open and ) two different preparations of factor VaKF, (crossed boxes) factor VaMI-AA, () factor VaMI-KF, () factor VaFF-AA, (+) factor VaI332A, and (x) factor VaW333A. The Km values for all cofactor molecules are given in Table 1, while the kcat values are shown in panel B (min-1). Panel C provides the second-order rate constants (M-1 s-1). The data represent the average values found in at least three different titrations for each recombinant factor Va molecule.
###end p 63
###begin title 64
Effect of the Mutations on Prothrombin Catalysis
###end title 64
###begin p 65
###xml 934 935 924 925 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 935 936 925 926 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
###xml 936 943 926 931 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">WT&#8594;KF</sub>
###xml 958 959 938 939 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 959 960 939 940 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
###xml 960 967 940 945 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">WT&#8594;AA</sub>
###xml 1015 1016 993 994 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sch1" ref-type="scheme">1</xref>
###xml 1141 1143 1119 1121 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 1296 1297 1266 1267 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1297 1300 1267 1270 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sub>
###xml 1353 1354 1323 1324 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="eq3" ref-type="disp-formula">3</xref>
###xml 1359 1360 1329 1330 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="eq4" ref-type="disp-formula">4</xref>
###xml 1435 1436 1405 1406 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sch1" ref-type="scheme">1</xref>
###xml 1471 1472 1433 1434 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1472 1475 1434 1437 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sub>
Prothrombinase is composed of factor Va and factor Xa assembled on a membrane surface in the presence of divalent metal ions. We can thus hypothesize that prothrombinase is an enzyme composed of two subunits: a catalytic subunit (factor Xa) and a regulatory subunit (factor Va). Any perturbation in the interaction between the two subunits or any perturbations in the interaction of prothrombinase with the substrate caused by a mutation in the regulatory subunit may influence (modify) the stability of the catalytic site of the catalytic subunit. Thus, the consequences of mutations in factor Va affecting factor Xa catalytic efficiency can be measured relative to the change in the transition-state stabilization free energy of the enzyme. The kinetic data showed that the DY --> KF/AA mutation in factor Va results in a decrease in the catalytic efficiency of factor Va which in turn is translated by positive values of DeltaDeltaGWT-->KF and DeltaDeltaGWT-->AA of 1.24 and 1.5 kcal/mol, respectively (Scheme 1). To quantify the interaction between these mutations and the mutations in the previously described factor Xa binding site (31) and their synergistic effects on prothrombinase function, we have calculated the difference in free energy of the transition-state analogue (DeltaDeltaGint) for each of the quadruple mutants according to eqs 3 and 4. We have also constructed a thermodynamic cycle of prothrombinase (Scheme 1). The positive value of DeltaDeltaGint for the combination of mutations at amino acids 323 and 324 and amino acids 330 and 331 with the DY --> KF mutation indicates that these substitutions in the heavy chain of factor Va are detrimental to the catalytic activity of prothrombinase.
###end p 65
###begin title 66
###xml 100 100 100 100 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sch1-fn1"/>
Thermodynamic Cycle for Prothrombinase Activity following Substitutions in the Factor Va Heavy Chain
###end title 66
###begin p 67
###xml 10 11 2 3 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 11 14 3 6 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sub>
###xml 77 80 69 72 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 81 84 73 76 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 90 93 82 85 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 94 97 86 89 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 99 102 91 94 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 103 106 95 98 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 164 165 156 157 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="eq3" ref-type="disp-formula">3</xref>
###xml 170 171 162 163 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="eq4" ref-type="disp-formula">4</xref>
###xml 185 185 177 177 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 242 243 226 227 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 243 244 227 228 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
DeltaDeltaGint is the free energy of interaction between the side chains of D334Y335 and E323Y324/E330V331 of the factor Va heavy chain and was calculated with eqs 3 and 4 described in . The values illustrated on the arrows are the DeltaDeltaG values between recombinant species as indicated. Parallel arrows show the difference in catalytic efficiency between prothrombinase assembled with different mutant factor Va molecules. Different forms of prothrombinase are compared for their ability to activate prothrombin.
###end p 67
###begin title 68
Structural Consequences of the Mutations
###end title 68
###begin p 69
###xml 122 125 122 125 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 131 134 131 134 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 354 356 354 356 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref19">19</xref>
###xml 389 391 389 391 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 504 506 504 506 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 660 662 660 662 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 742 743 742 743 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">6</xref>
###xml 782 784 782 784 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 811 814 811 814 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 820 823 820 823 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 888 890 888 890 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 893 896 893 896 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 902 905 902 905 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 928 929 928 929 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">6</xref>
###xml 949 951 949 951 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 954 957 954 957 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 963 966 963 966 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 989 990 989 990 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">6</xref>
###xml 1111 1114 1108 1111 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">321</sup>
###xml 1119 1122 1116 1119 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1143 1146 1140 1143 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">365</sup>
###xml 1151 1154 1148 1151 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">369</sup>
###xml 1208 1210 1205 1207 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1271 1273 1268 1270 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 1287 1289 1284 1286 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 1328 1331 1322 1325 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1337 1340 1331 1334 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">365</sup>
###xml 1492 1494 1483 1485 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref22">22</xref>
###xml 1495 1497 1486 1488 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 1498 1500 1489 1491 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 1522 1525 1513 1516 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">321</sup>
###xml 1527 1530 1518 1521 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1532 1535 1523 1526 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">365</sup>
###xml 1537 1540 1528 1531 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">369</sup>
###xml 1556 1559 1544 1547 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">321</sup>
###xml 1561 1564 1549 1552 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1566 1569 1554 1557 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">362</sup>
###xml 1571 1574 1559 1562 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">369</sup>
###xml 1591 1593 1579 1581 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 1615 1618 1603 1606 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">362</sup>
###xml 1673 1676 1661 1664 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 1724 1727 1712 1715 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 1729 1732 1717 1720 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 1751 1754 1735 1738 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 1756 1759 1740 1743 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 1928 1930 1912 1914 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
We next used the model of the factor Va molecule to understand the structural consequences of the mutations at positions D334 and Y335. It is important to underline that our MD simulations are tentative, especially with reference to interactions within the A2 domain, as this region is not present in any crystal structures and is derived from modeling (19). The MD simulation of factor VaWT reached equilibrium after 1 ns and was extended for an additional 1 ns for analysis. The simulation of factor VaKF reached equilibrium after 2.5 ns, and the simulation was extended to 3.5 ns for analysis of the last equilibrated nanosecond. The simulation of factor VaAA reached equilibrium at 2 ns, and the last 500 ps was used for analysis. Figure 6A shows the final snapshot of factor VaWT with amino acid residues D334 and Y335 shown as blue sticks. The corresponding amino acids in factor VaKF [K334 and F335, respectively (Figure 6B)] and in factor VaAA [A334 and A335, respectively (Figure 6C)] are also represented as blue sticks. The MD data show that the antiparallel beta-sheet contained in the region from R321 to V331 (first strand) and K365 to T369 (second strand) is preserved in the case of factor VaWT during the simulation. In contrast, in the case of factor VaAA and factor VaKF, the beta-sheets are extended at the V331 and K365 ends by three amino acids. This beta-sheet contains the critical amino acid sequence 323-331 previously shown to regulate factor Va cofactor activity (22,23,29). Elongation of the R321-V331/K365-T369 beta-sheet to R321-A334/H362-T369 in the factor VaAA molecule positioned H362 in a conformation that ensured hydrogen bonding with F538, thus directly affecting the stability of the S528-F538 alpha-helix. The S528-F538 helix is a continuation of the amino acid stretch that contains a secondary binding site of the cofactor for factor Xa that is located between amino acids 493 and 506 (24).
###end p 69
###begin p 70
###xml 119 122 119 122 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 124 127 124 127 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">699</sup>
###xml 127 129 127 129 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref30">30</xref>
###xml 130 132 130 132 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref54">54</xref>
###xml 133 135 133 135 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref55">55</xref>
###xml 127 135 127 135 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup>
###xml 195 198 191 194 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 200 203 196 199 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 281 283 277 279 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
###xml 319 322 312 315 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">321</sup>
###xml 324 327 317 320 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 329 332 322 325 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">365</sup>
###xml 334 337 327 330 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">369</sup>
###xml 412 414 405 407 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref22">22</xref>
###xml 415 417 408 410 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 418 420 411 413 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 560 563 553 556 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 569 572 562 565 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">362</sup>
###xml 601 604 594 597 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">412</sup>
###xml 631 634 624 627 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">534</sup>
###xml 640 643 633 636 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">364</sup>
###xml 691 694 684 687 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">530</sup>
###xml 700 703 693 696 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 736 739 729 732 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 806 808 799 801 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 855 858 848 851 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 864 867 857 860 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 951 953 944 946 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 992 995 985 988 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1003 1006 996 999 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 1014 1014 1007 1007 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 1027 1030 1020 1023 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">413</sup>
###xml 1036 1039 1029 1032 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">412</sup>
###xml 1098 1100 1091 1093 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 1139 1142 1132 1135 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1148 1151 1141 1144 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 657 661 <span type="species:ncbi:159033">lime</span>
Structural analyses of the factor V heavy chain. A portion of the prothrombin interactive site containing amino acids D695-Q69930,54,55 is shown as magenta spheres. The alpha-helix contained in S528-F538 is colored red. This region contains a secondary binding site for factor Xa (24). The beta-sheet contained in the R321-V331/K365-T369 sequence that is important for expression of factor Va cofactor activity (22,23,29) is colored yellow. The loop contained within the sequence of amino acid residues 400-420 is shown with cyan ribbons. Amino acid residues F538 and H362 are shown as green sticks. S412 is shown as cyan sticks. N534 and K364 are shown as lime sticks. Amino acid residues Y530 and E330 are shown as olive sticks, and E323 is shown as orange sticks. The final snapshot at 2 ns of factor VaWT is shown in panel A with amino acid residues D334 and Y335 represented as blue sticks. Panel B shows the final snapshot at 3.5 ns of factor VaKF with the mutated amino acid residues K334 and Phe335 as blue sticks and R413 and S412 as cyan sticks. Panel C is a snapshot at 2 ns of factor VaAA with the mutated amino acid residues A334 and A335 colored blue.
###end p 70
###begin title 71
Discussion
###end title 71
###begin p 72
Collectively, through a systematic approach, using both kinetic studies with synthetic peptides and recombinant proteins, our data demonstrate that amino acid region 334-335 plays an important role in the expression of factor Va cofactor activity. Our data also demonstrate the cofactor requirement for the efficient rearrangement of enzyme (factor Xa) and substrate (prothrombin) within prothrombinase necessary for efficient catalysis of prothrombin at two spatially distinct sites. However, it is important to note that our study does not provide a definitive mechanism detailing the involvement of amino acid region 334-335 of factor Va in cofactor activity.
###end p 72
###begin p 73
###xml 66 73 66 71 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">DY&#8594;KF</sup>
###xml 386 387 384 385 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 387 388 385 386 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 461 462 447 448 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 462 463 448 449 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 530 533 516 519 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 541 544 527 530 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 616 618 602 604 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 1231 1238 1217 1222 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">DY&#8594;KF</sup>
The mechanism of inhibition of prothrombinase function by AP5, AP5DY-->KF, AP6, and IWDYA was investigated by assessing factor Va cofactor activity in the presence of increasing concentrations of synthetic peptide. These data show that the IWDYA motif shared by AP5 and AP6 contains the amino acids that account for the inhibitory effect of the peptides. This is evident in the similar Ki values of peptides AP6 and IWDYA. AP5 has an approximately10-fold lower Ki value than AP6 and IWDYA, because it also contains amino acids Glu330 and Val331, which have been previously shown to be involved in factor Xa binding (29). Analysis of the mode of inhibition of prothrombinase by AP5 suggests that the peptide is a mixed-type inhibitor and interacts with both prothrombinase and prothrombinase bound to the substrate (prothrombin). Thus, while it is possible that AP5 interacts with prothrombinase in the presence and absence of prothrombin, the possibility that AP5 also binds prothrombin when the enzyme is in complex with the substrate must be kept in mind. Finally, within the peptide sequence IWDYA, amino acids D and Y are contributing to its function, since substitution of these two amino acids with K and F, respectively (AP5DY-->KF), results in the almost complete loss of the inhibitory potential of AP5.
###end p 73
###begin p 74
###xml 373 374 373 374 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 374 375 374 375 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 395 397 395 397 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 411 413 411 413 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 447 448 447 448 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 448 449 448 449 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 462 464 462 464 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 568 570 568 570 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 584 586 584 586 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
Site-directed mutagenesis was used to assess the importance of amino acid region 334-335 from the factor Va heavy chain during prothrombin catalysis. The data show that mutating this amino acid region results in a factor Va molecule that when incorporated into prothrombinase produces an enzyme with an overall 10-fold decrease in its second-order rate constant. Since the KD values of factor VaKF and factor VaAA for factor Xa are similar to the KD of factor VaWT for the enzyme, the data strongly suggest that the inability of prothrombinase assembled with factor VaKF and factor VaAA to function optimally can be explained by the inability of factor Xa to efficiently convert prothrombin to thrombin because of a diminished number of productive collisions.
###end p 74
###begin p 75
###xml 78 80 78 80 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 95 97 95 97 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 153 154 153 154 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 154 155 154 155 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 225 227 225 227 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 241 243 241 243 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 400 405 400 401 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sup>
###xml 1115 1118 1111 1114 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 1120 1123 1116 1119 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">324</sup>
###xml 1134 1136 1130 1132 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">FF</sup>
###xml 1142 1145 1138 1141 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">330</sup>
###xml 1147 1150 1143 1146 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 1161 1163 1157 1159 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">MI</sup>
###xml 1188 1191 1184 1187 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1193 1196 1189 1192 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 1214 1216 1210 1212 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 1229 1231 1225 1227 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
The results obtained from the MD simulations of wild-type factor Va, factor VaKF, and factor VaAA were able to offer an explanation both for the similar KD values found for the interaction of wild-type factor Va and factor VaKF (or factor VaAA) with factor Xa and for the impaired clotting and cofactor activity of both mutant molecules. The modeling data demonstrate that the distances between the Calpha atoms of amino acids 334 and 323, 334 and 324, 335 and 323, and 335 and 324 analyzed separately do not change significantly when comparing wild-type factor Va with the mutant molecules. Thus, there are no changes in the overall conformation of the segment of amino acids 323-331 because of the mutations. The combined data rather suggest that the difference in the distance of the centers of mass between the two amino acid segments observed is due to the presence of different amino acid side chains that interact with each other. Coincidentally, the thermodynamic and kinetic data obtained herein also suggest that combination of the mutations at the extremities of the factor Xa binding site in factor Va, 323EY324 (factor VaFF) and 330EV331 (factor VaMI), with mutations in the 334DY335 region (factor VaKF or factor VaAA) have an additive detrimental effect on prothrombinase with respect to prothrombin activation. It is also important to note that replacement of an aspartic acid with an alanine appeared to be more detrimental to cofactor activity than replacement with lysine. These data would suggest that the negative charge per se at residue 334 is not critical for cofactor activity. Finally, we must point out that tentative explanations using our theoretical model are suggestive rather than conclusive and await verification that will be obtained from the crystal structure of the recombinant mutated cofactor molecule.
###end p 75
###begin p 76
###xml 256 258 256 258 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 272 274 272 274 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 806 808 806 808 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 822 824 822 824 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
At this point, it is important to underline the complementarities of all the data provided in this paper. Our findings using the MD simulations demonstrate that in the presence of the mutations there is a relocation of the COOH-terminal region of factor VaKF and factor VaAA as compared with the wild-type cofactor molecule. However, these calculations are unable to distinguish whether the changes will enhance or decrease the catalytic efficiency of the prothrombinase complex assembled with the mutated cofactor molecule. On the other hand, the kinetic, thermodynamic, and molecular biology data demonstrate a detrimental effect of the mutations on cofactor activity without providing a structural explanation. Together, the data suggest that the internal rearrangement at the COOH terminus of factor VaKF and factor VaAA is detrimental to the overall catalytic efficiency of factor Xa as part of prothrombinase. Therefore, the MD simulations using the only complete structure of factor Va in solution available in the literature are useful in providing a theoretical explanation for the decrease in the second-order rate constant of prothrombinase assembled with the mutant cofactor molecules.
###end p 76
###begin title 77
Acknowledgement
###end title 77
###begin p 78
We thank Dr. Ken Mann and Dr. Tom Orfeo from the University of Vermont for providing the monoclonal antibodies to factor V and Dr. Alex Kurosky and Steve Smith from the University of Texas, Medical Branch, for quantitative amino acid analysis and mass spectrometry analyses of the synthetic peptides.
###end p 78
###begin title 79
Supporting Information Available
###end title 79
###begin p 80
###xml 397 416 397 416 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>
Figure S1 shows the kinetic analyses of prothrombin activation by prothrombinase in the presence of AP3. Panel A shows the Michaelis-Menten plots, while panel B shows the mathematical transformation of the data using Dixon plots. Figure S2 shows prothrombin activation by prothrombinase assembled with recombinant factor Va molecules. This material is available free of charge via the Internet at http://pubs.acs.org.
###end p 80
###begin title 81
Supplementary Material
###end title 81
###begin p 82
bi800057r-File015.pdf
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
The regulation of clotting factors.
###end article-title 84
###begin article-title 85
Factor V: Dr. Jeckyll and Mr. Hyde.
###end article-title 85
###begin article-title 86
Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.
###end article-title 86
###begin article-title 87
###xml 120 126 <span type="species:ncbi:9913">bovine</span>
The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.
###end article-title 87
###begin article-title 88
The conversion of prothrombin to thrombin. II. Differentiation between thrombin- and factor Xa-catalyzed proteolyses.
###end article-title 88
###begin article-title 89
The conversion of prothrombin to thrombin. III. The factor Xa-catalyzed activation of prothrombin.
###end article-title 89
###begin article-title 90
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism.
###end article-title 90
###begin article-title 91
###xml 20 26 <span type="species:ncbi:9913">bovine</span>
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.
###end article-title 91
###begin article-title 92
The kinetics and cofactor dependence of the two cleavages involved in prothrombin activation.
###end article-title 92
###begin article-title 93
A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions.
###end article-title 93
###begin article-title 94
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human prothrombin activation.
###end article-title 94
###begin article-title 95
###xml 21 26 <span type="species:ncbi:9606">human</span>
Primary structure of human prethrombin 2 and alpha-thrombin.
###end article-title 95
###begin article-title 96
###xml 25 27 25 27 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Prothrombin fragments. Ca2+ binding and activation kinetics.
###end article-title 96
###begin article-title 97
Characteristics of the association between prothrombin fragment 2 and alpha-thrombin.
###end article-title 97
###begin article-title 98
Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process.
###end article-title 98
###begin article-title 99
###xml 33 38 <span type="species:ncbi:9606">human</span>
Thrombin-catalyzed activation of human coagulation factor V.
###end article-title 99
###begin article-title 100
Characterization of Factor V activation intermediates.
###end article-title 100
###begin article-title 101
###xml 57 63 <span type="species:ncbi:9913">bovine</span>
The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.
###end article-title 101
###begin article-title 102
###xml 37 42 <span type="species:ncbi:9606">human</span>
Completed three-dimensional model of human coagulation factor Va. Molecular dynamics simulations and structural analyses.
###end article-title 102
###begin article-title 103
Contribution of the heavy and light chains of factor Va to the interaction with factor Xa.
###end article-title 103
###begin article-title 104
Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction: Analysis by analytical ultracentrifugation.
###end article-title 104
###begin article-title 105
The Role of the Membrane in the Inactivation of Factor Va by Plasmin: Amino Acid Region 307-348 of Factor V Plays a Critical Role in Factor Va Cofactor Function.
###end article-title 105
###begin article-title 106
Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X.
###end article-title 106
###begin article-title 107
Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
###end article-title 107
###begin article-title 108
###xml 49 54 <span type="species:ncbi:9606">human</span>
Complete cDNA and derived amino acid sequence of human factor V.
###end article-title 108
###begin article-title 109
###xml 30 36 <span type="species:ncbi:9913">bovine</span>
The complete cDNA sequence of bovine coagulation factor V.
###end article-title 109
###begin article-title 110
###xml 30 36 <span type="species:ncbi:10090">murine</span>
The structure and function of murine factor V and its inactivation by protein C.
###end article-title 110
###begin article-title 111
Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains.
###end article-title 111
###begin article-title 112
Amino acids Glu323, Tyr324, Glu330, and Val331 of factor Va heavy chain are essential for expression of cofactor activity.
###end article-title 112
###begin article-title 113
A Control Switch for Prothrombinase. Characterization of a Hirudin-Like Pentapeptide From the COOH Terminus of Factor Va Heavy Chain that Regulates the Rate and Pathway for Prothrombin Activation.
###end article-title 113
###begin article-title 114
Incorporation of factor Va into prothrombinase is required for coordinated cleavage of prothrombin by factor Xa.
###end article-title 114
###begin article-title 115
Identification of an inactivating cleavage site for alpha-thrombin on the heavy chain of factor Va.
###end article-title 115
###begin article-title 116
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
###end article-title 116
###begin article-title 117
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications.
###end article-title 117
###begin article-title 118
The contribution of amino acid residues 1508-1515 of factor V to light chain generation.
###end article-title 118
###begin article-title 119
###xml 19 24 <span type="species:ncbi:9606">human</span>
The interaction of human factor VIIa with tissue factor.
###end article-title 119
###begin article-title 120
The binding of activated protein C to factors V and Va.
###end article-title 120
###begin article-title 121
Effects of site-specific amino acid modification on protein interactions and biological function.
###end article-title 121
###begin article-title 122
Long-range, small magnitude nonadditivity of mutational effects in proteins.
###end article-title 122
###begin article-title 123
Additivity of mutational effects in proteins.
###end article-title 123
###begin article-title 124
Quantitative interpretations of double mutations of enzymes.
###end article-title 124
###begin article-title 125
Inverse thinking about double mutants of enzymes.
###end article-title 125
###begin article-title 126
SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling.
###end article-title 126
###begin article-title 127
GROMACS: A message-passing parallel molecular dynamics implementation.
###end article-title 127
###begin article-title 128
GROMACS 3.0: A package for molecular simulation and trajectory analysis.
###end article-title 128
###begin article-title 129
Interaction models for water in relation to protein hydration, in
###end article-title 129
###begin article-title 130
LINCS: A linear constraint solver for molecular simulations.
###end article-title 130
###begin article-title 131
Particle mesh Ewald: An N.log(N) method for Ewald sums in large systems.
###end article-title 131
###begin article-title 132
A smooth particle mesh Ewald method.
###end article-title 132
###begin article-title 133
Molecular dynamics with coupling to an external bath.
###end article-title 133
###begin article-title 134
Structure and pair potentials: A molecular-dynamics study.
###end article-title 134
###begin article-title 135
Structural requirements for expression of factor Va activity.
###end article-title 135
###begin article-title 136
The contribution of amino acid region ASP695-TYR698 of factor V to procofactor activation and factor Va function.
###end article-title 136

